Abstract
Objective: This study compared the clinical features and hemodynamic characteristics of patients in different Suzuki stages of ischemic moyamoya disease (iMMD) before and after treatment with extracranial-intracranial (EC-IC) bypass surgery combined with encephalo-duro-myo-synangiosis and whole-brain computed tomography perfusion (WB-CTP).Methods: A total of 126 patients in different Suzuki stages (II, III, IV, and V) of iMMD who underwent bypass surgery from April 2013 to August 2020 were included in this retrospective study. MIStar automatic analysis of Whole brain CT perfusion imaging software (WB-CTP, Apollo Medical Imaging Technology, Melbourne, Australia) was used. The patients also underwent WB-CTP 1 day before and 1 week and 3 months after the surgery. The relationships between hemodynamic parameters in WB-CTP including delay time (DT) > 3 s, relative cerebral blood flow (rCBF) < 30%, mismatch and mismatch ratio, and clinical outcomes were evaluated for different Suzuki stages, with comparisons between early (II and III) and late (IV and V) stages.Results: Combined bypass surgery was performed in 161 hemispheres of 126 patients with iMMD. Brain volume with DT > 3 s was decreased 1 week (51.5 ± 11.8 ml, P < 0.05) and 3 months (41.5 ± 10.7 ml, P < 0.05) after bypass compared to 1 day before bypass (104.7 ± 15.1 ml) in early-stage patients. In late-stage patients, the volume was increased 1 week after bypass compared to the preoperative value (154.3 ± 14.7 vs. 118.3 ± 19.1 ml, P < 0.05). Preoperative brain volume with rCBF < 30% was lower (9.8 ± 3.9 vs. 33.5 ± 11.0 ml) whereas preoperative mismatch ratio was higher (11.2 ± 2.8 vs. 3.6 ± 1.6) in early-stage as compared to late-stage patients (both P < 0.05). A higher modified Rankin scale score (0–1) was achieved by early-stage patients than by those in the late stage (93.8 vs. 80.4%, P < 0.05) at the 3-month follow-up.Conclusions: WB-CTP is useful for assessing the effectiveness of combined bypass/revascularization in different Suzuki stages of iMMD. Patients in the early stage of disease with higher preoperative brain volume with DT > 3 s and mismatch ratio show greater improvements in hemodynamic parameters and fewer postoperative complications associated with hemodynamic disturbance following bypass than patients in the late stage. Preoperative mismatch ratio can serve as a marker for assessing the status of collateral circulation in different Suzuki stages of iMMD.
Highlights
Moyamoya disease (MMD) can lead to severe ischemic stroke in adolescent and adult patients [1]
Whole-brain computed tomography perfusion (WB-computed tomography perfusion (CTP)) has been applied to moyamoya disease (MMD) to assess the feasibility of revascularization, the relationship between Suzuki stage, WBCTP features, and clinical outcomes has not been reported [7]
We investigated the hemodynamic features in WB-CTP of ischemic (i) MMD patients in different Suzuki stages before and after EC-IC revascularization combined with EDAMS, and evaluated the relationship between hemodynamic parameters and clinical outcomes in different Suzuki stages
Summary
Moyamoya disease (MMD) can lead to severe ischemic stroke in adolescent and adult patients [1]. The consistency between pre- and postoperative hemodynamic characteristics in patients with iMMD in different Suzuki stages, and whether these parameters are related to postoperative complications, is not known. Whole-brain computed tomography perfusion (WB-CTP) is a useful technique for screening patients with ischemic stroke for treatment with mechanical recanalization or intravenous thrombolysis within a narrow time window [5, 6]. WB-CTP has been applied to MMD to assess the feasibility of revascularization, the relationship between Suzuki stage, WBCTP features, and clinical outcomes has not been reported [7]. We investigated the hemodynamic features in WB-CTP of ischemic (i) MMD patients in different Suzuki stages before and after EC-IC revascularization combined with EDAMS, and evaluated the relationship between hemodynamic parameters and clinical outcomes in different Suzuki stages
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.